Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Side Effect Management

Feature Video
Beth Fand Incollingo
A retrospective study found that clinical trials may have fewer reported side effects than the real world.
Brielle Benyon
A smartphone app helped significantly reduce pain and hospital visits for patients with metastatic solid tumors.
Jane Biehl, Ph.D.
It is not the type of fatigue where a good night’s sleep will “cure” us. It just seems to go on and on.
Katie Kosko
Preventing febrile neutropenia is crucial because the body’s white blood cells help to fight infection.
Kristie L. Kahl
The Food and Drug Administration (FDA) approved Udenyca (pegfilgrastim-cbqv), a biosimilar to Neulasta (pegfilgrastim), according to Coherus Biosciences, the biosimilar’s manufacturer.
Jane Biehl, Ph.D.
When it comes to routine eye checkups and other appointments not directly related to my cancer, I become lax.
Katie Kosko
Patients can use daily practices to help reduce stress and anxiety.
Kristie L. Kahl
The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.
Jane Biehl, Ph.D.
There are dozens of potential side effects, and more are being reported every month.
Jessica Skarzynski
Here are the top 5 CURE stories for September 2018.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other